Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Size And Growth In 2026: Key Factors Shaping Future Demand
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Growth Potential: How Will Market Size Shift Through 2030?
The topical drugs contract development and manufacturing organization (CDMO) market has experienced rapid expansion recently. It is projected to increase from $61.16 billion in 2025 to $70.96 billion in 2026, showcasing a compound annual growth rate (CAGR) of 16.0%. The growth observed in the historic period can be ascribed to elements such as the increase in pharmaceutical outsourcing, a rising prevalence of dermatological conditions, cost optimization efforts by pharmaceutical companies, escalating regulatory complexity, and the wider expansion of generic topical drugs.
The topical drugs contract development and manufacturing organization (cdmo) market is poised for substantial expansion over the next few years. It is forecast to grow to $121.22 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%. This projected growth during the forecast period is driven by the increasing development of sophisticated topical therapies, a rising need for transdermal patches, the expansion of product pipelines within small and mid-sized pharmaceutical companies, a growing demand for scalable manufacturing capabilities, and an enhanced focus on expediting market entry. Significant trends anticipated in this period include an increase in the outsourcing of topical drug manufacturing, a surging requirement for complex topical formulations, the broadening of transdermal drug delivery platforms, a heightened emphasis on manufacturing processes that comply with regulations, and a greater inclination towards comprehensive end-to-end CDMO services.
Get A Free Sample Report With In-Depth Market Insights:
Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Growth Factors: What’s Supporting Expansion?
The burgeoning incidence of dermal ailments is projected to stimulate expansion within the topical drugs contract development and manufacturing organization (CDMO) market in the coming years. These conditions encompass various medical issues impacting the integumentary system, leading to symptoms like inflammation, pruritus, and skin lesions. A rise in these skin conditions stems from contributing factors including environmental pollution, exposure to UV radiation, genetic susceptibility, shifts in lifestyle, and microbial infections. The topical drugs contract development and manufacturing organization (CDMO) contributes to mitigating the frequency of skin diseases through the creation and production of specific treatments designed to enhance the management and care of dermatological ailments. An illustrative example is seen in 2023, where Cancer Australia, a government agency located in Australia, reported roughly 8,257 fresh diagnoses of melanoma of the skin, which represented 2.6% of all cancer-related fatalities. Consequently, the rising occurrence of skin diseases is a key impetus for the expansion of the topical drugs contract development and manufacturing organization (CDMO) market.
Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Segment Trends And Revenue Contributors
The topical drugs contract development and manufacturing organization (cdmo) market covered in this report is segmented –
1) By Product Type: Semi-Solid Formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products
2) By Service Type: Contract Development, Contract Manufacturing
3) By Therapeutic Area: Dermatology, Pain Management, Wound Care, Ophthalmology, Other Therapeutic Areas
4) By End-Use: Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Uses
Subsegments:
1) By Semi-Solid Formulations: Creams, Ointments, Gels, Pastes
2) By Liquid Formulations Drugs: Solutions, Suspensions, Emulsions, Lotions
3) By Solid Formulations: Powders
4) By Transdermal Products: Patches
Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Industry Trends: What’s Reshaping Demand?
Major entities within the topical drugs contract development and manufacturing organization (CDMO) market are concentrating on establishing highly advanced production sites to maintain their standing. A state-of-the-art manufacturing facility is a specialized production location outfitted with the newest technology and sophisticated methods specifically tailored for the creation and production of topical pharmaceutical items. For instance, in November 2023, SOHM Inc., a US-based pharmaceutical company, opened a CDMO GMP manufacturing facility. The new Carlsbad facility is set to provide generous space for producing topical products and for SOHM’s operations, with 2,500 square feet designated for storing finished goods. Initially, it will possess a daily manufacturing capacity of 500 gallons (1,892 liters) for topicals. By the end of Q1 2024 or the start of Q2 2024, an expansion of its capacity to include soft-gel suppositories is anticipated.
Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the topical drugs contract development and manufacturing organization (cdmo) market are Catalent Inc., Lonza Group AG, Recipharm AB, Piramal Pharma Solutions, Cambrex Corporation, PCI Pharma Services, Famar S.A., Contract Pharmaceuticals Limited, UPM Pharmaceuticals Inc., MedPharm Ltd, Tergus Pharma LLC, NextPharma Technologies Holding Limited, Bora Pharmaceuticals Co. Ltd., LTS Lohmann Therapie-Systeme AG, CoreRx Inc., Halo Pharmaceutical Inc., Tapemark Company, Groupe PARIMA Inc., Dow Development Laboratories LLC, Tedor Pharma Inc.
View The Full Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Report:
Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Geographic Analysis: Where Is Demand Rising Fastest?
Asia-Pacific was the largest region in the topical drugs contract development and manufacturing organization (CDMO) market in 2025. The regions covered in the topical drugs contract development and manufacturing organization (cdmo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
